Varian Medical Systems Inc. (NYSE:VAR) insider Dow R. Wilson sold 10,000 shares of the firm’s stock in a transaction dated Monday, November 7th. The stock was sold at an average price of $90.59, for a total value of $905,900.00. Following the sale, the insider now directly owns 70,598 shares in the company, valued at approximately $6,395,472.82. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Varian Medical Systems Inc. (NYSE:VAR) opened at 88.85 on Friday. The firm has a market cap of $8.33 billion, a price-to-earnings ratio of 21.21 and a beta of 0.67. Varian Medical Systems Inc. has a 52-week low of $73.18 and a 52-week high of $106.70. The firm’s 50 day moving average price is $95.39 and its 200 day moving average price is $89.80.

Varian Medical Systems (NYSE:VAR) last announced its earnings results on Wednesday, October 26th. The company reported $1.38 EPS for the quarter, beating the consensus estimate of $1.34 by $0.04. Varian Medical Systems had a return on equity of 26.57% and a net margin of 12.51%. The company had revenue of $912 million for the quarter, compared to analyst estimates of $880.29 million. During the same quarter in the prior year, the company earned $1.04 EPS. The firm’s revenue for the quarter was up 11.5% compared to the same quarter last year. Equities research analysts anticipate that Varian Medical Systems Inc. will post $4.93 EPS for the current fiscal year.

Insider Buying and Selling by Quarter for Varian Medical Systems (NYSE:VAR)

Several large investors have recently made changes to their positions in VAR. First Eagle Investment Management LLC raised its stake in shares of Varian Medical Systems by 35.3% in the second quarter. First Eagle Investment Management LLC now owns 4,325,749 shares of the company’s stock valued at $355,706,000 after buying an additional 1,128,626 shares during the last quarter. Emerald Acquisition Ltd. acquired a new stake in shares of Varian Medical Systems during the second quarter valued at approximately $43,974,000. Loomis Sayles & Co. L P raised its stake in shares of Varian Medical Systems by 8.7% in the second quarter. Loomis Sayles & Co. L P now owns 5,903,578 shares of the company’s stock valued at $485,451,000 after buying an additional 474,506 shares during the last quarter. Nordea Investment Management AB raised its stake in shares of Varian Medical Systems by 287.4% in the second quarter. Nordea Investment Management AB now owns 590,879 shares of the company’s stock valued at $48,588,000 after buying an additional 438,348 shares during the last quarter. Finally, BlackRock Fund Advisors raised its stake in shares of Varian Medical Systems by 12.6% in the second quarter. BlackRock Fund Advisors now owns 3,183,332 shares of the company’s stock valued at $261,765,000 after buying an additional 357,316 shares during the last quarter. Institutional investors own 99.77% of the company’s stock.

VAR has been the topic of a number of research analyst reports. Jefferies Group raised their price target on Varian Medical Systems from $95.00 to $98.00 and gave the stock a “buy” rating in a research report on Thursday, July 28th. Brean Capital raised their price target on Varian Medical Systems from $87.00 to $90.00 and gave the stock a “buy” rating in a research report on Thursday, July 28th. Citigroup Inc. lifted their target price on Varian Medical Systems from $84.00 to $88.00 and gave the company a “neutral” rating in a research report on Thursday, July 28th. Morgan Stanley lifted their target price on Varian Medical Systems from $80.00 to $86.00 and gave the company an “underweight” rating in a research report on Thursday, July 28th. Finally, Barrington Research dropped their target price on Varian Medical Systems from $102.00 to $93.00 and set an “outperform” rating on the stock in a research report on Thursday, July 28th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and three have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $93.38.

About Varian Medical Systems

Varian Medical Systems Inc is a manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy. The Company is a supplier of X-ray imaging components for medical, scientific, and industrial applications and supplies X-ray imaging products for cargo screening and industrial inspection.

5 Day Chart for NYSE:VAR

Receive News & Stock Ratings for Varian Medical Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Varian Medical Systems Inc. and related stocks with our FREE daily email newsletter.